Follow-The-Filings

Security · featured owners

ELVN Enliven Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 4.5%
  • $28M
  • 1 new 1 add

Who owns this now

Largest portfolio weights among featured holders · max 4.5% (David Witzke - Avidity Pa...) · not free-float ownership

  1. David Witzke add 4.5%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 4.5% Add +37.5% 550,000 $28M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% New <0.01% 7,500 $381K history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$71.58M -$89.02M -$103.69M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $266.15M $318.13M $474.88M
Total non-current assets * $5.72M $7.63M $1.29M
Total assets $271.87M $325.76M $476.17M
Total current liabilities $25.89M $15.92M $16.57M
Total non-current liabilities * $67,000 $0.00 $0.00
Total equity $245.91M $309.84M $459.6M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$61.27M -$73.19M -$70.3M
Cash from investing -$148.41M -$36M -$173.84M
Cash from financing $234.29M $133.16M $218.87M
Net change in cash * $24.6M $23.98M -$25.28M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders